EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Muno-IgY Supplementation Improves Respiratory Health, Immune Response, and Exercise-Induced Physiological Stress in Healthy Adults: A Randomized Controlled Pilot Study

Shahna Fathima iD, Paul E Kilgore iD, Tina Sarkar, Navneet Sharma, Huan H Nguyen iD

Nutrients · 2026

DOI: 10.3390/nu18030524 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Shahna Fathima und 4 weiteren Autor:innen. Beteiligte Einrichtung: IGY Immune Technologies & Life Sciences Inc., 4 East Lake Ave NE, Unit 1A, Airdrie, AB T4A2G8, Canada. Hauptthemen laut MEDLINE: Dietary Supplements, Respiratory Tract Infections, Exercise, Stress, Physiological. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IGY Immune Technologies and Life Sciences Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Upper respiratory tract infections (URTIs) and exercise-induced immune perturbations are common in adults and may adversely affect quality of life, productivity, and physical performance. Immunoglobulin Y (IgY), a food-derived antibody with broad antimicrobial activity, has demonstrated immunomodulatory potential in preclinical and limited clinical studies. This study evaluated the effects of a multi-pathogen-specific IgY supplement (Muno-IgY) on respiratory health, immune and inflammatory markers, exercise-induced physiological stress, and gut microbiome composition in healthy adults.

Methods

In this 12-week, double-blind, placebo-controlled trial, 28 healthy adults with a history of URTI were randomly allocated to receive Muno-IgY or placebo and URTI incidence, duration, and severity were recorded daily. Serum immune and inflammatory biomarkers were assessed longitudinally and in response to a standardized exercise challenge. Gut microbiome composition was analyzed using shotgun metagenomic sequencing at baseline and week 12. Safety and tolerability were assessed throughout the study.

Results

URTI incidence was lower in the Muno-IgY group compared with placebo (14.3% vs. 35.7%), with shorter average duration and fewer missed workdays, though differences were not statistically significant (p > 0.05). Following an acute exercise challenge, Muno-IgY supplementation resulted in a significant increase in serum IgA at 24 h post-exercise (p = 0.022) and a significantly greater reduction in lactate dehydrogenase at 1 h post-exercise compared with placebo (p < 0.0001). Exploratory gut microbiome analyses suggested favorable directional shifts, though these changes were not statistically tested.

Conclusions

In this exploratory pilot study, Muno-IgY supplementation was safe and associated with significant improvements in selected markers of exercise-induced immune response and muscle damage. Numerical trends in URTI incidence and gut microbiome composition were observed but were not statistically significant. These findings are hypothesis-generating and support further evaluation of Muno-IgY in larger, adequately powered clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsRespiratory Tract InfectionsExerciseStress, PhysiologicalImmunoglobulinsHumansPilot ProjectsAdultMaleFemaleDouble-Blind MethodYoung AdultGastrointestinal MicrobiomeBiomarkers

Stichwörter der Autor:innen

gut healthgut microbiomegut–lung axisimmune responseimmunoglobulin Yinflammationmucosal immunitynutraceuticalsnutritional immunologyquality of life

Substanzen

ImmunoglobulinsBiomarkers

Autor:innen und Institutionen

  • IGY Immune Technologies & Life Sciences Inc., 4 East Lake Ave NE, Unit 1A, Airdrie, AB T4A2G8, Canada.
  • Clinical Research Center, CS Mott Center for Human Growth and Development, Wayne State University, Detroit, MI 48201, USA.
  • Center for Emerging and Infectious Diseases, Wayne State University, Detroit, MI 48201, USA.
  • Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.

ORCID-Profile: Shahna Fathima, Paul E Kilgore, Huan H Nguyen

Förderung

  • IGY Immune Technologies and Life Sciences Inc.

Zitieren

APA

Fathima, S., Kilgore, P. E., Sarkar, T., Sharma, N., & Nguyen, H. H. (2026). Muno-IgY Supplementation Improves Respiratory Health, Immune Response, and Exercise-Induced Physiological Stress in Healthy Adults: A Randomized Controlled Pilot Study. Nutrients. https://doi.org/10.3390/nu18030524

Vancouver

Fathima S, Kilgore PE, Sarkar T, Sharma N, Nguyen HH. Muno-IgY Supplementation Improves Respiratory Health, Immune Response, and Exercise-Induced Physiological Stress in Healthy Adults: A Randomized Controlled Pilot Study. Nutrients. 2026. doi:10.3390/nu18030524

BibTeX
@article{Fathima2026,
  author = {Fathima, Shahna and Kilgore, Paul E and Sarkar, Tina and Sharma, Navneet and Nguyen, Huan H},
  title = {Muno-IgY Supplementation Improves Respiratory Health, Immune Response, and Exercise-Induced Physiological Stress in Healthy Adults: A Randomized Controlled Pilot Study},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18030524}
}
Kostenlos starten →